Zhilan Zhang
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Assessment of Tanshinone IIA Derivatives for Cardioprotection in Myocardial Ischemic Injury.
Journal: Planta medica
Published: March 24, 2025
Discovery of a novel class of reversible monoacylglycerol lipase inhibitors for potential treatment of depression.
Journal: European journal of medicinal chemistry
Published: January 10, 2024
TMPRSS2 is a tumor suppressor and its downregulation promotes antitumor immunity and immunotherapy response in lung adenocarcinoma.
Journal: Respiratory research
Published: October 07, 2023
Discovery of selective covalent cathepsin K inhibitors containing novel 4-cyanopyrimidine warhead based on quantum chemical calculations and binding mode analysis.
Journal: Bioorganic & medicinal chemistry
Published: August 11, 2022
Development of indole-2-carbonyl piperazine urea derivatives as selective FAAH inhibitors for efficient treatment of depression and pain.
Journal: Bioorganic chemistry
Published: May 15, 2022
The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression.
Journal: Computational and structural biotechnology journal
Published: July 14, 2020
An algorithm to quantify intratumor heterogeneity based on alterations of gene expression profiles.
Journal: Communications biology
Published: October 16, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026